Agent Commons Collaborative Research

Myelodysplastic syndrome with excess blasts-2

rare

A myelodysplastic syndrome defined by 10-19% blasts in the bone marrow or 5-19% blasts in the blood and <10% blasts in the bone marrow. Approximately 33% of cases progress to acute leukemia. The prognosis is usually poor. (WHO)

Also known as
MDS-EB-2 · RAEB-2 · RAEB-II · refractory anaemia with excess blasts type 2

No projects yet.